Squamous cell carcinoma, or cutaneous squamous cell carcinoma, is a malignant skin tumour that arises from the flat skin cells called keratinocytes. These cells form the upper layer of the skin and help protect the body from the external environment. When DNA damage accumulates in these cells and they begin to grow uncontrollably, squamous cell carcinoma can develop.
Squamous cell carcinoma belongs to the group of non-melanoma skin cancers. The most common non-melanoma skin cancers are basal cell carcinoma and squamous cell carcinoma. Squamous cell carcinoma is not the same as basal cell carcinoma, and it is not the same as melanoma. It is usually more dangerous than basal cell carcinoma because it has a higher risk of spreading, or metastasising, especially when the tumour is large, deep, recurrent, located on the lip, ear, scalp, fingers, feet, in a scar or chronic wound, or when the patient has a weakened immune system.
Squamous cell carcinoma most often develops on sun-damaged skin: the face, ears, lower lip, scalp, neck, backs of the hands, forearms and other areas that have received a lot of ultraviolet radiation over a lifetime. However, it can also develop in chronic wounds, scars, areas of inflammation or long-term irritation, as well as on mucous membranes, for example in the mouth or genital area.
Squamous cell carcinoma may look like a rough or scaly patch, a red firm nodule, a wart-like growth, a non-healing ulcer, a crust or a bleeding skin lesion. It is not always dark. It is often pink, red, skin-coloured, yellowish and crusted or scaly. It is important not to wait until the lesion becomes very large or clearly painful. If a skin lesion does not go away, grows, bleeds, oozes, ulcerates, forms a crust, hurts or becomes tender, it should be shown to a dermatologist.
Squamous cell carcinoma is not an infection and is not contagious. It cannot be caught from another person. It develops as a result of cell damage and uncontrolled growth. The main risk factor is ultraviolet radiation from the sun and tanning beds, but actinic keratosis, weakened immunity, chronic wounds, scars, certain viral infections in specific locations, smoking and previous skin cancer can also play a role.
Squamous cell carcinoma is a skin cancer that develops from keratinocytes — the cells that form the upper layer of the skin. This tumour is also called cutaneous squamous cell carcinoma, squamous cell cancer or squamous cell skin cancer.
The word “carcinoma” means a malignant tumour that arises from epithelial cells. In the skin, the epithelium is the upper layer of the skin, or epidermis. Therefore, squamous cell carcinoma is a malignant skin tumour, not simply a “rough patch”, “wart” or “non-healing crust”.
Squamous cell carcinoma may be early, when the abnormal cells are located only in the upper layer of the skin, or invasive, when the tumour grows deeper into the skin and surrounding tissues. Invasive squamous cell carcinoma has a higher risk of spreading to lymph nodes or other parts of the body.
For a broader overview of different types of skin cancer, see the article Skin cancer.
Yes. Squamous cell carcinoma is one of the main types of non-melanoma skin cancer. Non-melanoma skin cancer means that the tumour is not melanoma. The most common non-melanoma skin cancers are basal cell carcinoma and squamous cell carcinoma.
This classification is important because melanoma, basal cell carcinoma and squamous cell carcinoma differ in origin, appearance, severity, diagnosis and treatment approach. Melanoma is more often associated with pigment cells and changes in moles, basal cell carcinoma more often grows slowly and locally, while squamous cell carcinoma is often associated with sun-damaged skin, rough or scaly lesions and a higher risk of spreading than basal cell carcinoma.
No. Squamous cell carcinoma and basal cell carcinoma are different types of skin cancer.
Basal cell carcinoma arises from the basal cells of the skin. It usually grows slowly and very rarely spreads through the body, but it can damage tissues locally. Squamous cell carcinoma arises from the flat skin cells, or keratinocytes. Compared with basal cell carcinoma, it is more likely to grow deeper, become painful, ulcerate, bleed and, in certain cases, spread to lymph nodes.
In simple terms: basal cell carcinoma is more often a slow-growing local tumour, while squamous cell carcinoma is a tumour in which timely diagnosis is especially important because of the risk of spreading.
For a related topic, see the article Basal cell carcinoma.
Melanoma arises from melanocytes — pigment cells. It is often associated with changes in a mole, asymmetry, multiple colours, irregular borders or a new dark or unusual lesion.
Squamous cell carcinoma arises from keratinocytes, and it more often looks like a rough, scaly, thickened, painful, crusted or ulcerated skin lesion. It is not always pigmented and is often not dark. It may look like a non-healing wound or a wart-like growth.
Overall, melanoma is more dangerous in terms of metastatic potential, but squamous cell carcinoma can also be serious, especially in high-risk cases.
For a related topic, see the article Melanoma.
Usually yes — squamous cell carcinoma has a higher risk of spreading than basal cell carcinoma. However, this does not mean that every case of squamous cell carcinoma is equally dangerous. Some squamous cell carcinomas are detected early and successfully treated with local treatment.
The level of danger depends on the tumour size, depth, location, histological features, recurrence, the patient’s immune status and whether the tumour has already spread to lymph nodes or elsewhere.
Squamous cell carcinoma can look different from case to case. It may be flat or raised, pink or red, skin-coloured, rough, scaly, crusted, ulcerated or bleeding. Sometimes it resembles a wart, a thickened area of skin, a chronic wound or a “crust that does not go away”.

Typical appearances include:
At first, squamous cell carcinoma may look similar to actinic keratosis — a rough, sun-damaged patch. However, if the patch becomes thicker, painful, bleeds, ulcerates, oozes, grows quickly or looks like a nodule, it should be examined by a dermatologist.
A skin lesion is especially suspicious if it becomes thicker, more painful, starts oozing, ulcerating, bleeding or growing faster within a relatively short period of time. Squamous cell carcinoma does not always develop slowly and unnoticed — in some cases, a patient notices that a previously small rough patch or crust has quickly become a raised, tender or bleeding lesion.
No. Squamous cell carcinoma is usually not dark like melanoma. It is more often pink, red, skin-coloured, yellowish and crusted, scaly or ulcerated. Dark colour is not the main sign. It is much more important that the lesion does not go away, grows, becomes thicker, bleeds, hurts, ulcerates or forms a crust.
Squamous cell carcinoma may not hurt, especially in the beginning. However, compared with basal cell carcinoma, it is more likely to become tender, painful, inflamed or bleeding. It may also itch, sting, ooze or cause discomfort.
Pain, bleeding, oozing or crusting are not the only signs, but they are important warning signals, especially if the lesion is located on the lip, ear, scalp, hand, finger, foot, scar or long-term sun-damaged skin.
Squamous cell carcinoma is most often noticed through practical changes on the skin. The following signs are especially important.

If there is a rough, dry or scaly patch on sun-damaged skin that persists for a long time, becomes thicker or changes, it should be assessed by a dermatologist.
A wound that does not heal for several weeks, opens again, bleeds, oozes or becomes covered with a crust may be a sign of squamous cell carcinoma.
Squamous cell carcinoma may look like a raised, firm, pink or red nodule that grows or becomes tender.
Sometimes the tumour can resemble a wart — it may be raised, rough, thickened or have a crusted surface.
If a lesion repeatedly bleeds, hurts, itches, becomes tender or forms a crust, it should not be observed at home for a long time.
Squamous cell carcinoma is often linked to sun-damaged skin and precancerous changes. Two especially important terms are actinic keratosis and Bowen’s disease.

Actinic keratosis is a sun-damaged skin change that usually looks like a rough, dry, scaly or sandpaper-like patch. It often appears on the face, ears, scalp, lips, backs of the hands, forearms and other sun-exposed areas.
Actinic keratosis itself is not yet an invasive skin cancer, but it is considered a precancerous condition. This means that some of these lesions can progress to squamous cell carcinoma, especially if they become thicker, painful, bleeding, oozing or ulcerated.
If there are many actinic keratoses on the skin, this may indicate broader sun damage in that area of skin. This situation is sometimes called field cancerisation — meaning that the risk is not only in one visible patch, but in the entire UV-damaged skin field. Therefore, a dermatologist may recommend treating not only a single lesion, but also a wider area of sun-damaged skin.
For a related topic, see the article Actinic keratosis.
Yes, actinic keratosis can turn into squamous cell carcinoma, but this does not happen with every lesion. What matters practically for the patient is not trying to predict the risk at home, but showing a dermatologist rough, changing, painful, bleeding, oozing or thickening patches.
Actinic keratoses on the lip, ears, scalp, backs of the hands and areas with extensive sun damage should be assessed especially carefully.
Bowen’s disease is squamous cell carcinoma in situ. This means that the malignant cells are located in the upper layer of the skin and have not yet grown deeper. It may look like a red, scaly, slowly growing patch that can resemble eczema, psoriasis or a fungal infection.
Bowen’s disease should be treated because some cases may become invasive. The treatment method is chosen by a doctor based on the location, size, number of lesions and the patient’s health status.
A rough patch should be shown to a dermatologist if it:
Squamous cell carcinoma most often develops in sun-damaged areas. Common locations include:
However, squamous cell carcinoma can also develop in areas that are not regularly exposed to the sun, especially where there is long-term inflammation, a chronic wound, a scar, a burn scar, an ulcer or risk related to immunosuppression.
Lesions on the lip, ear, scalp, fingers, toes, palms, soles, scars and chronic wounds should be assessed particularly carefully. In these locations, lesions may be noticed later or be associated with more complex treatment.
Yes. Squamous cell carcinoma can develop on the lip, especially the lower lip, which often receives sun exposure. Warning signs may include roughness, long-lasting dryness, a crack, ulcer, crust, bleeding, thickening or soreness on the lip.
The lip is an important location because squamous cell carcinoma in this area may be higher risk than many superficial skin lesions. Therefore, persistent roughness or an ulcer on the lip should not be treated only as “dry lips”.
Yes. The ear and scalp are important locations. On the ear, squamous cell carcinoma may look like a painful, crusted, bleeding or rough lesion. On the scalp, the lesion can be harder to notice, especially if a person does not check this area themselves.
Lesions in these areas should not be ignored for a long time, because diagnosis may be delayed and treatment may become more complicated.
Yes. Squamous cell carcinoma can also develop on the fingers, toes, palms and soles. In these areas it may be mistaken for a wart, injury, ingrown nail, chronic fissure or non-healing wound.
If there is a lesion on a finger, foot or palm that grows, hurts, bleeds, thickens, does not heal or repeatedly forms a crust, it should not be treated for a long time as a wart or injury without a doctor’s assessment.
Yes. Squamous cell carcinoma can develop in chronic wounds, ulcers, burn scars or areas of long-term inflammation. These tumours are sometimes described as carcinomas developing on the background of chronic damage. They may be higher risk than some sun-damage-related tumours.
If a new thickening, ulceration, bleeding, pain, unpleasant smell, oozing or growing lesion appears in the area of a scar, ulcer or chronic wound, a medical examination is needed.
Yes. Squamous cell carcinoma can also develop on mucous membranes, for example in the mouth or genital area. These cases may differ from classic sun-induced cutaneous squamous cell carcinoma in terms of risk factors, diagnosis and treatment. In certain locations, HPV infection, smoking, chronic irritation or other factors may be important.
This article mainly describes cutaneous squamous cell carcinoma. If the lesion is located in the mouth, throat, genital area or other mucous membranes, the diagnostic and treatment pathway may differ, and the involvement of an appropriate specialist is needed.
In the mouth, warning signs may include a non-healing ulcer, a white or red patch, thickening, pain or bleeding. In the genital area, suspicious findings include non-healing, ulcerated, thickened or bleeding lesions. In such cases, the appropriate specialist should be consulted — a dermatologist, venereologist, gynaecologist, urologist, dentist or oncologist, depending on the location.
Squamous cell carcinoma develops when DNA damage accumulates in skin cells and the cells begin to divide uncontrollably. The main cause of this damage is ultraviolet radiation from the sun and tanning beds. UV radiation damages the genetic material of cells, and over time these changes can lead to precancerous changes and tumour development.
Squamous cell carcinoma is not an infection and is not contagious. It does not pass from one person to another through touch, shared towels, swimming pools or everyday contact.
In certain locations or specific situations, the risk of squamous cell carcinoma can also be increased by chronic inflammation, scars, long-standing wounds, weakened immunity, certain chemicals, ionising radiation, HPV infection and smoking.
In the case of squamous cell carcinoma, it is more accurate to talk about a development mechanism rather than a mechanism of infection, because it is not a contagious infectious disease.
In simple terms, development can be described as follows:
This process is not the same in every patient. In some people, lesions remain as rough patches for years, while in others changes may progress faster, especially in the setting of weakened immunity or a high-risk tumour.
The development of squamous cell carcinoma can vary, but it can be explained to patients in several stages.
Over the years, the sun or tanning beds damage skin cells. The skin may become rougher, more blotchy, thinner, with pigment changes and small blood vessels.
Rough, dry, scaly patches appear on sun-damaged skin. These may be precancerous lesions. Not every such patch becomes cancer, but they should be assessed.
Abnormal cells are located in the upper layer of the skin. This condition may be called Bowen’s disease. It is not yet a tumour that has grown deeply, but it should be treated.
The tumour grows deeper into the skin. It may become painful, thickened, ulcerated, oozing, bleeding and enlarged.
In high-risk cases, the tumour can spread to lymph nodes or other parts of the body. Therefore, timely diagnosis and treatment are essential.
Squamous cell carcinoma can develop in anyone, but the risk is higher in certain groups.
The risk is increased in people who have:
Fair skin increases the risk because it contains less melanin — the pigment that partially protects against UV radiation. However, squamous cell carcinoma can also occur in people with darker skin, especially in scars, chronic wounds or areas that are not regularly checked.
Yes. In people after organ transplantation and in people receiving long-term immunosuppressive therapy, the risk of squamous cell carcinoma is significantly higher. The immune system helps the body control atypical cells and viral infections. When immune function is suppressed, the risk and aggressiveness of skin cancers can increase.
For these patients, regular dermatologist check-ups, sun protection and rapid response to new or changing skin lesions are especially important.
Most squamous cell carcinomas are not directly hereditary. However, a person can inherit skin type, sensitivity to the sun or rare genetic diseases that increase skin cancer risk. Family history may be important if skin cancer occurs frequently in the family or at a young age.
Yes. If a person has already had squamous cell carcinoma, they have a higher risk of developing another squamous cell carcinoma, basal cell carcinoma or another skin cancer in the future. This is related to shared risk factors — accumulated UV damage, skin type, immunity and individual predisposition.
Therefore, regular skin follow-up is important after treatment.
You should see a dermatologist if there is a lesion on the skin or mucous membrane that:
You should not wait until the lesion becomes very painful. Squamous cell carcinoma can be treatable when detected early, but delayed diagnosis increases treatment complexity.
Diagnosis begins with a dermatologist’s examination. The doctor assesses the lesion’s appearance, size, location, surface, crusting, ulceration, bleeding, oozing, pain, growth rate and risk factors. If the lesion is on the lip, ear, scalp, finger, foot, in a scar, chronic wound or the patient has weakened immunity, the doctor assesses high-risk features especially carefully.
Dermoscopy is often performed. Dermoscopy is examination of a skin lesion with an optical device called a dermatoscope. It allows structures that are not visible to the naked eye to be seen under magnification. Dermoscopy helps distinguish squamous cell carcinoma from actinic keratosis, basal cell carcinoma, a wart, inflammation or other skin lesions, but histology is often needed for the final diagnosis.

For related topics, see the articles Dermoscopy and Skin lesion examination.
A biopsy means taking a tissue sample for microscopic examination. It is needed if the lesion is suspicious for squamous cell carcinoma or if the diagnosis cannot be safely established by examination and dermoscopy alone.
A biopsy helps determine:
In some cases, the doctor may recommend removing the entire lesion at once and sending it for histological examination.
Histological examination is the microscopic assessment of tissue. It is important because squamous cell carcinoma can resemble actinic keratosis, basal cell carcinoma, a wart, a chronic wound, inflammation or another skin lesion.
Histology helps determine the tumour type, depth, differentiation, invasion, margins and other features that influence the treatment plan and the risk of recurrence or metastasis.
Lymph nodes should be assessed if squamous cell carcinoma is high-risk or if there are clinical signs that may suggest spread. The doctor may examine the nearest lymph nodes by palpation, but if needed, ultrasound, imaging or other investigations may be recommended.
Lymph node assessment may be especially important if the tumour is large, deep, recurrent, located on the lip, ear, scalp, in a scar or chronic wound, if the patient has weakened immunity, or if high-risk features are found on histology.
No. A photograph may help understand whether a lesion looks suspicious, but it does not replace a doctor’s examination, dermoscopy and histological examination. Squamous cell carcinoma can look similar to actinic keratosis, a wart, basal cell carcinoma, eczema, an ulcer or inflammation.
Therefore, a suspicious lesion should not be assessed only by internet images or an artificial intelligence answer.
Squamous cell carcinoma can be difficult to recognise, especially in the beginning. It can be confused with:
If the lesion does not go away, grows, bleeds, oozes, hurts, thickens or forms an ulcer, a dermatologist’s examination is needed.
Treatment of squamous cell carcinoma depends on tumour size, depth, location, histological features, spread, recurrence risk and the patient’s general health. The aim of treatment is to completely remove or destroy the tumour, reduce the risk of recurrence, preserve function and achieve the best possible aesthetic result.

Main treatment options include:
In practice, treatment can be divided into low-risk and high-risk situations. A small, superficial, clearly defined lesion in a low-risk location may require simpler treatment. A large, deep, painful, recurrent, fast-growing tumour, or a tumour on the lip, ear, scalp, in a scar, chronic wound or in an immunosuppressed patient, should be treated more carefully, often with lymph node assessment and involvement of a surgeon or oncologist.
This article does not list specific prescription medicines. Treatment may only be determined by a doctor after diagnosis, histology and individual risk assessment.
Yes, squamous cell carcinoma that is diagnosed early and treated completely can often be cured. The prognosis is better if the tumour is small, superficial, has not spread and is treated in time.
However, delaying treatment can increase tumour depth, recurrence risk, the extent of scarring and the possibility of spread. Tumours on the lip, ear, scalp, fingers, feet, scars, chronic wounds and in people with weakened immunity should be treated especially carefully.
Not always, but surgical excision is one of the main and most commonly used methods for treating invasive squamous cell carcinoma. Surgery allows the tumour to be removed and the tissue sent for histological examination to confirm the diagnosis and assess the margins.
For superficial or in situ lesions, in selected situations a doctor may choose other methods, such as topical therapy, photodynamic therapy or other procedures. However, in invasive, high-risk or deeper squamous cell carcinoma, treatment must be sufficiently radical to reduce the risk of recurrence and spread.
During surgical excision, the doctor removes the tumour together with a certain safety margin of healthy tissue. This safety margin is needed to reduce the risk that tumour cells remain in the skin. After excision, the tissue is sent for histological examination.
The extent of excision depends on the tumour size, depth, location and risk. In the face, lip, ear or scalp area, treatment planning may be more complex because both safe tumour removal and function and cosmetic outcome must be considered.
Mohs micrographic surgery is a method in which the tumour is removed step by step, with the tissue margins checked under a microscope during treatment. This allows precise control of tumour removal and preserves more healthy skin.
Mohs surgery may be especially important for:
The availability and suitability of this method are assessed by a doctor.
Radiotherapy may be used when surgery is not suitable, when the tumour is in a complex location, when the patient’s health does not allow surgery, or when additional local control is needed after treatment. Radiotherapy may also be used in selected cases when the tumour has spread or there is a high risk of recurrence.
The decision about radiotherapy is made by a specialist team after assessing tumour and patient factors.
Some superficial lesions or squamous cell carcinoma in situ can, in certain situations, be treated with doctor-prescribed topical prescription therapy. However, invasive squamous cell carcinoma usually cannot be treated safely with cream alone.
Self-treatment with over-the-counter products, acids, folk remedies or products recommended online is not safe and can delay diagnosis.
Laser is not a universal or standard method for treating invasive squamous cell carcinoma. A suspicious lesion must not simply be “removed with laser” without a diagnosis and treatment plan, because tissue histology may be needed for diagnosis, risk assessment and treatment planning.
Cryotherapy and photodynamic therapy may be suitable for selected superficial lesions or precancerous changes, such as actinic keratosis or some in situ lesions. They are not suitable for all squamous cell carcinomas, especially if the tumour is invasive, deep, painful, high-risk or located in an important area.
The method is chosen by a doctor after diagnosis and risk assessment.
Systemic therapy means treatment that acts on the whole body. It may be needed in rare cases when squamous cell carcinoma is locally very advanced, cannot be treated completely with local methods, or has spread to lymph nodes or other organs.
In such cases, an oncologist is involved in treatment. The specific type of therapy is chosen according to tumour spread, histology, the patient’s health status and other factors.
An oncologist is involved if squamous cell carcinoma is high-risk, advanced, recurrent, affects lymph nodes, cannot be completely removed with simple local treatment, or if radiotherapy or systemic therapy is needed.
Sometimes the treatment plan is developed by a multidisciplinary team — a dermatologist, surgeon, oncologist, radiation therapist, pathologist and other specialists.
After surgical excision, a scar usually remains. The appearance of the scar depends on the tumour size, location, extent of excision, individual wound healing and post-operative care.
In the face, lip, ear or scalp area, the doctor must plan not only safe tumour removal, but also preservation of function and aesthetic outcome. However, the main goal is always complete and safe tumour treatment.
No. Squamous cell carcinoma must not be treated at home. Self-treatment can delay diagnosis, cause infection, scarring, bleeding or allow the tumour to continue growing.
A suspicious lesion should not be burned, cut, scratched, “dried out”, treated with acids or managed according to internet advice. If the lesion is non-healing, rough, bleeding, painful or growing, a dermatologist should be consulted.
A suspicious skin lesion should not be:
A suspicious lesion should first be assessed by a doctor. If needed, dermoscopy, biopsy or excision with histological examination should be performed.
Yes, squamous cell carcinoma can be dangerous. Many cases are treatable if detected early, but squamous cell carcinoma has a higher risk of spreading than basal cell carcinoma. It can grow deeper into tissues, damage surrounding structures, recur after treatment and, in certain cases, spread to lymph nodes or other parts of the body.
Yes, squamous cell carcinoma can metastasise, although most early treated cases do not spread. The risk of metastasis is higher if the tumour is large, deep, poorly differentiated, recurrent, located on the lip, ear, scalp or in a scar, or if the patient has weakened immunity.
Most often, squamous cell carcinoma may first spread to the nearest lymph nodes.
Untreated squamous cell carcinoma can continue to grow, become deeper, more painful, bleed, ooze, ulcerate and damage surrounding tissues. It can lead to a larger scar and more complex treatment. In high-risk cases, it can spread to lymph nodes or elsewhere in the body.
Therefore, squamous cell carcinoma should not be postponed simply because the lesion seems “small” or is not very painful at first.
Yes. If the tumour is located on the lip, ear, nose or other anatomically sensitive areas, it can grow deeper and damage tissues that have important functional and aesthetic significance. Treatment in these locations must be planned especially carefully.
Yes, squamous cell carcinoma can return, or recur. The risk of recurrence depends on the tumour’s risk features, location, histology, treatment method and whether the tumour was removed completely.
After treatment, regular follow-up is important because a person may develop not only recurrence, but also a new squamous cell carcinoma, basal cell carcinoma or another skin cancer.
High-risk features may include:
In high-risk cases, treatment and follow-up are usually more intensive.
The prognosis is usually good when squamous cell carcinoma is detected early and treated completely. The prognosis becomes more serious if the tumour is large, deep, recurrent, poorly differentiated, located in a high-risk area or has spread to lymph nodes.
The prognosis is influenced by:
The risk of squamous cell carcinoma cannot be reduced to zero, but it can be lowered by limiting UV radiation and treating precancerous changes in time.

The most important prevention principles are:
When used correctly, SPF helps reduce skin damage caused by UV radiation. However, SPF is not the only protective measure and is not permission to stay in the sun longer. Combined protection works best: shade, clothing, a hat, sunglasses, sunscreen and avoiding tanning beds.
Yes, actinic keratosis should be assessed and treated according to a doctor’s instructions, especially if there are many lesions, they become thicker, hurt, bleed or are located in high-risk areas. Treating actinic keratosis can help reduce the risk of squamous cell carcinoma developing in that specific skin field.
If there are many actinic keratoses, the goal of treatment may be not only to remove a single patch, but also to control the entire sun-damaged skin field. This helps reduce the risk of new precancerous and cancerous lesions.
Intentional sunbathing is not recommended. After a squamous cell carcinoma diagnosis, the skin should be protected especially carefully, because UV damage is one of the main risk factors and the person may have an increased risk of new skin cancers.
This does not mean that you cannot go outside, but sunburn, tanning beds and prolonged intense sun exposure should be avoided.
The frequency of follow-up is determined by the doctor. It depends on tumour risk, location, treatment method, histology, immune status and whether the patient has had other skin cancers.
High-risk patients usually need more frequent follow-up. It is important to check the skin regularly and contact a doctor promptly if a new, changing, bleeding, painful or non-healing lesion appears.
During skin self-checks, examine:
For checking the back and scalp, help from a close person or a mirror may be useful. If a person has extensive sun damage, actinic keratoses or previous skin cancer, self-checks do not replace dermatologist follow-up.
It is medically well established that ultraviolet radiation is an important risk factor for squamous cell carcinoma. The link between actinic keratosis and some squamous cell carcinomas is also well established, as is the role of weakened immunity in increasing tumour risk and aggressiveness.
Evidence-based diagnosis includes a doctor’s examination, dermoscopy and histological examination if the lesion is suspicious. In treatment, complete removal or destruction of the tumour with an appropriate method is essential, taking tumour risk into account.
Medicine continues to improve the identification of high-risk squamous cell carcinoma in order to better understand which patients need more intensive treatment and follow-up. Digital dermoscopy, skin lesion photography, artificial intelligence support tools and personalised risk assessment are developing.
For advanced or metastatic squamous cell carcinoma, systemic treatment approaches continue to develop, including immunotherapy-type treatment in certain situations. Such treatment is not needed for most early squamous cell carcinomas, but it may be important in complex cases where the tumour cannot be fully treated with local methods.
The information in this article is intended for informational and educational purposes and does not replace medical consultation, diagnosis or treatment. Self-assessment of skin and mucosal lesions may be wrong because squamous cell carcinoma can resemble actinic keratosis, a wart, eczema, a chronic wound, basal cell carcinoma, melanoma or other skin changes. If you notice a new, growing, bleeding, painful, itchy, crusted, oozing, non-healing or otherwise suspicious skin or mucosal lesion, consult a dermatologist, dermato-oncologist, surgeon, oncologist or an appropriate specialist according to the location, such as a dentist, gynaecologist or urologist. Do not try to treat, burn, cut, scratch or remove suspicious lesions on your own. If the lesion grows rapidly, bleeds significantly, ulcerates, becomes very painful, signs of infection appear, lymph nodes enlarge or general symptoms occur, urgent medical assessment is needed.
Yes. Squamous cell carcinoma is a skin cancer that develops from the cells of the outer layer of the skin, known as keratinocytes.
Yes. It is a malignant tumour that can grow deeper into tissue and in certain cases spread.
Yes. It belongs to the non-melanoma skin cancer group together with basal cell carcinoma.
No. They are different types of skin cancer. Squamous cell carcinoma generally carries a greater risk of spreading than basal cell carcinoma.
It may appear as a rough or scaly patch, a red nodule, a wart-like lesion, an ulcer or a crust.
Yes. A rough or scaly patch that does not clear up, becomes thicker, hurts or bleeds should be shown to a dermatologist.
Yes. A non-healing ulcer or wound can be a sign of squamous cell carcinoma.
It may not hurt, but can become painful, tender, itchy or bleed.
Most commonly on sun-damaged skin: the face, lip, ears, scalp, neck, backs of hands and forearms.
Yes. The lower lip is particularly significant, where persistent roughness, a sore or a crust should be assessed by a doctor.
Yes. In these locations it can resemble a wart, injury or chronic wound, so non-healing or growing lesions should be assessed by a doctor.
Yes, some actinic keratoses can progress to squamous cell carcinoma, especially if they become thicker, painful or bleed.
Bowen's disease is squamous cell carcinoma in situ — an early form in which the abnormal cells are still confined to the outer layer of the skin.
Through a dermatologist's examination, dermoscopy and, if necessary, biopsy or excision with histological examination.
No. A photograph does not replace a doctor's examination and histological investigation.
Treatment may include surgical excision, Mohs surgery, radiation therapy, selected local methods or systemic therapy in advanced cases.
Yes, squamous cell carcinoma detected early and fully treated can often be cured.
Not always, but for invasive squamous cell carcinoma surgical treatment is often the primary method.
Yes, it can metastasise, especially in high-risk cases. The nearest lymph nodes are most commonly affected first.
This is possible, especially in neglected, metastatic or high-risk cases, but for disease treated early the prognosis is often good.
It can grow deeper, bleed, ulcerate, damage surrounding tissue and in certain cases spread.
Yes. It can recur, which is why follow-up after treatment is necessary.
Large, deep, recurrent tumours, tumours on the lip, ear, scalp, in scars, in chronic wounds, on fingers, on feet or in patients with weakened immunity.
Avoid sunburn and sunbeds, use sun protection, treat actinic keratoses and have your skin checked regularly.
Yes, correctly used SPF reduces UV damage, but should be combined with clothing, shade and avoiding sunbeds.
No. It is not an infection and is not contagious.
It is rare in children, but possible in special situations such as genetic diseases, immunosuppression or previous radiation therapy.
If a lesion does not clear up, grows, thickens, hurts, bleeds, weeps, forms a crust or is located on the lip, ear, scalp, in a scar or in a chronic wound.
No. Many skin lesions are benign, but changing, non-healing, painful or bleeding lesions should be assessed by a dermatologist.
Yes. After one skin cancer the risk of developing another in the future increases, which is why follow-up is important.
Deliberate sun exposure is not recommended. UV damage, sunbeds and sunburn should be avoided.
| Qualification | Clients of the clinic | First visit |
|---|---|---|
| Dr. Med. | 66.50 € | 70 € |
| Highly qualified doctor | 52.25 € | 55 € |
| Doctor | 45 € | 55 € |
The final price of a skin lesion examination consists of the consultation fee and the fee for each additional skin lesion examined dermatoscopically, if more than one skin lesion is examined (please note that the consultation fee depends on the doctor’s qualification).
An in-depth examination with a dermatoscope is offered only for medium-risk and high-risk lesions.
For example, if during the consultation a dermatologist (doctor’s consultation fee — 55 €) observes two suspicious skin lesions, and the patient agrees to have both skin lesions examined with a dermatoscope (examination of the first skin lesion is included in the consultation fee + 10 € for each additional one), the total cost of the consultation will be 65 € (55 € + 10 €).
| Doctor’s qualification | Consultation fee |
|---|---|
| Doctor | 55 € |
| Highly qualified doctor | 55 € |
| Dr. med. | 70 € |
| Procedure | Price per item |
|---|---|
| Examination of one skin lesion | included in the consultation fee |
| For each additional one | 10 € |
Dermatologist Dr. Med. assistant professor Māra Rone-KupfereAsk a question Make an appointment |
|
Dermatologist Dr. med. Dace BuileAsk a question Make an appointment |
Dermatologist Gunita BuiksaAsk a question Make an appointment |
|
Dermatologist Ilona ZablockaAsk a question Make an appointment |
|
Dermatologist Zanda BogdanovaAsk a question Make an appointment |







